Combined cardiological and neurological abnormalities due to filamin A gene mutation

Marie Claire Y de Wit1, Irenaeus F M de Coo, Maarten H Lequin

  • 1Department of Neurology, Erasmus MC, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.

Insights

Mutations in the FLNA gene can cause cardiac defects and cerebral malformations. Early recognition of cardiac symptoms may lead to earlier diagnosis of FLNA-associated neurodevelopmental disorders.

Area of Science:

  • Genetics
  • Cardiology
  • Neurology

Background:

  • Mutations in the X-linked Filamin A (FLNA) gene are associated with cardiac defects, particularly in the left ventricular outflow tract.
  • FLNA gene dysfunction can also lead to congenital cerebral cortical malformations.

Observation:

  • Researchers identified 24 patients with bilateral periventricular nodular heterotopia (PNH) from a cerebral malformations database.
  • Six of these patients had pathogenic FLNA mutations, and five also presented with outflow tract cardiac defects.

Findings:

  • Four patients with FLNA mutations and PNH were initially seen by a cardiologist before their neurological condition was diagnosed.
  • The study highlights that FLNA mutations can manifest with cardiac issues before neurological symptoms are apparent.

Implications:

  • Recognizing cardiac abnormalities, such as aortic regurgitation or coarctation of the aorta, in patients with neurological complaints may suggest an underlying FLNA mutation.
  • Considering FLNA gene mutations in cases of X-linked cardiac and neurological disorders, especially with hyperlaxity, can improve diagnostic timelines.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...